114 related articles for article (PubMed ID: 38706059)
21. Tanshinone IIA enhances the inhibitory effect of imatinib on proliferation and motility of acute leukemia cell line TIB‑152 in vivo and in vitro by inhibiting the PI3K/AKT/mTOR signaling pathway.
Teng Z; Xu S; Lei Q
Oncol Rep; 2020 Feb; 43(2):503-515. PubMed ID: 31894340
[TBL] [Abstract][Full Text] [Related]
22. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.
Rao J; Xu DR; Zheng FM; Long ZJ; Huang SS; Wu X; Zhou WH; Huang RW; Liu Q
J Transl Med; 2011 May; 9():71. PubMed ID: 21595920
[TBL] [Abstract][Full Text] [Related]
23. Apoptosis induction in MV4-11 and K562 human leukemic cells by Pereskia sacharosa (Cactaceae) leaf crude extract.
Asmaa MJ; Al-Jamal HA; Ang CY; Asan JM; Seeni A; Johan MF
Asian Pac J Cancer Prev; 2014; 15(1):475-81. PubMed ID: 24528077
[TBL] [Abstract][Full Text] [Related]
24. Silencing of suppressor of cytokine signaling-3 due to methylation results in phosphorylation of STAT3 in imatinib resistant BCR-ABL positive chronic myeloid leukemia cells.
Al-Jamal HA; Jusoh SA; Yong AC; Asan JM; Hassan R; Johan MF
Asian Pac J Cancer Prev; 2014; 15(11):4555-61. PubMed ID: 24969884
[TBL] [Abstract][Full Text] [Related]
25. Anticancer Effect and Apoptosis Induction of Gambogic Acid in Human Leukemia Cell Line K562 In Vitro.
Chen J; Zhou M; Zhang Q; Xu J; Ouyang J
Med Sci Monit; 2015 Jun; 21():1604-10. PubMed ID: 26049398
[TBL] [Abstract][Full Text] [Related]
26. Characterization of imatinib-resistant K562 cell line displaying resistance mechanisms.
Hekmatshoar Y; Ozkan T; Altinok Gunes B; Bozkurt S; Karadag A; Karabay AZ; Sunguroglu A
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):23-30. PubMed ID: 29808796
[TBL] [Abstract][Full Text] [Related]
27. Tyrosine kinase inhibitor resistance in chronic myeloid leukemia cell lines: investigating resistance pathways.
Tang C; Schafranek L; Watkins DB; Parker WT; Moore S; Prime JA; White DL; Hughes TP
Leuk Lymphoma; 2011 Nov; 52(11):2139-47. PubMed ID: 21718141
[TBL] [Abstract][Full Text] [Related]
28. Anti-leukemic effects of gallic acid on human leukemia K562 cells: downregulation of COX-2, inhibition of BCR/ABL kinase and NF-κB inactivation.
Chandramohan Reddy T; Bharat Reddy D; Aparna A; Arunasree KM; Gupta G; Achari C; Reddy GV; Lakshmipathi V; Subramanyam A; Reddanna P
Toxicol In Vitro; 2012 Apr; 26(3):396-405. PubMed ID: 22245431
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxic effect of 6-Shogaol in Imatinib sensitive and resistant K562 cells.
Ozkan T; Hekmatshoar Y; Pamuk H; Ozcan M; Yaman G; Yagiz GC; Akdemir C; Sunguroglu A
Mol Biol Rep; 2021 Feb; 48(2):1625-1631. PubMed ID: 33515349
[TBL] [Abstract][Full Text] [Related]
30. [Inhibitory effect of alantolactone on the proliferation of K562/ADR cells and its mechanism].
Yang C; Cai H; Yan J; Yang J; Sun M; Meng X; Ma T
Zhonghua Xue Ye Xue Za Zhi; 2014 Jun; 35(6):515-8. PubMed ID: 24985175
[TBL] [Abstract][Full Text] [Related]
31. Proliferation-attenuating and apoptosis-inducing effects of tryptanthrin on human chronic myeloid leukemia K562 cell line in vitro.
Miao S; Shi X; Zhang H; Wang S; Sun J; Hua W; Miao Q; Zhao Y; Zhang C
Int J Mol Sci; 2011; 12(6):3831-45. PubMed ID: 21747710
[TBL] [Abstract][Full Text] [Related]
32. The molecular mechanisms of Tanshinone IIA on the apoptosis and arrest of human esophageal carcinoma cells.
Wang JF; Feng JG; Han J; Zhang BB; Mao WM
Biomed Res Int; 2014; 2014():582730. PubMed ID: 24829906
[TBL] [Abstract][Full Text] [Related]
33. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
34. [Inhibitory effect of thalidomide combined with interferon on the proliferation of Kasumi-1 cells].
Xu H; Mi R; Fan R; Yin Q; Wang X; Wei X
Zhonghua Xue Ye Xue Za Zhi; 2015 Sep; 36(9):743-7. PubMed ID: 26462773
[TBL] [Abstract][Full Text] [Related]
35. Proteasome inhibitor bortezomib overcomes P-gp-mediated multidrug resistance in resistant leukemic cell lines.
Zheng B; Zhou R; Gong Y; Yang X; Shan Q
Int J Lab Hematol; 2012 Jun; 34(3):237-47. PubMed ID: 22145750
[TBL] [Abstract][Full Text] [Related]
36. [Tanshinone IIA inhibits hypoxia/reoxygenation-induced cardiomyocyte apoptosis and autophagy by regulating ABCE1].
Xing L; Qiao W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Jun; 35(6):627-632. PubMed ID: 37366130
[TBL] [Abstract][Full Text] [Related]
37. Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation.
Lee YL; Chen CW; Liu FH; Huang YW; Huang HM
PLoS One; 2013; 8(4):e61939. PubMed ID: 23613979
[TBL] [Abstract][Full Text] [Related]
38. A combination of STI571 and BCR-ABL1 siRNA with overexpressed p15INK4B induced enhanced proliferation inhibition and apoptosis in chronic myeloid leukemia.
Xia DY; Liu L; Hao MW; Liu Q; Chen RA; Liang YM
Braz J Med Biol Res; 2014 Dec; 47(12):1096-101. PubMed ID: 25387678
[TBL] [Abstract][Full Text] [Related]
39. [Effect of total saponin of aralia taibaiensis on proliferation of leukemia cells].
Fan Y; Guo DY; Song Q; Li T
Zhong Yao Cai; 2013 Apr; 36(4):604-7. PubMed ID: 24134011
[TBL] [Abstract][Full Text] [Related]
40. Stellettin B induces apoptosis in human chronic myeloid leukemia cells via targeting PI3K and Stat5.
Chen Y; Zhou Q; Zhang L; Zhong Y; Fan G; Zhang Z; Wang R; Jin M; Qiu Y; Kong D
Oncotarget; 2017 Apr; 8(17):28906-28921. PubMed ID: 28423649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
